Readystate Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.82M Buy
2025
Q1
Sell
2024
Q4
$3.59M Sell
2024
Q3
$6.1M Buy
2024
Q2
Sell
2024
Q1
$2.08M Buy